José Luis Revuelta-Herrero (J L Revuelta-Herrero, Jose Luis Revuelta-Herrero)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 7

Top Topics

Prostate Cancer

Quality Control

Oxide Nanoparticles

Top Venues

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Journal of personalized medicine

International journal of clinical pharmacy

Expert opinion on drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Juan Vicente-Valor, Vicente Escudero-Vilaplana, Roberto Collado-Borrell, Cristina López-López, Cristina Villanueva-Bueno, José Luis Revuelta-Herrero, Paula Ruiz-Briones, Beatriz Somoza-Fernández, Ana Herranz, María Sanjurjo
Potential negative pharmacodynamic interaction of spironolactone and abiraterone in two prostate cancer patients. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)
Priscila Villalvazo, Belén Marzal-Alfaro, Pilar García Alfonso, José Luis Revuelta-Herrero, Fabienne Thomas, Sara López-Tarruella, Xandra García, Aitana Calvo, Malika Yakoubi, Sara Salvador-Martín, Flora López-López, Iker Aguilar, María Sanjurjo-Sáez, Miguel Martin, Luis Andrés López-Fernández
DPYD Exome, mRNA Expression and Uracil Levels in Early Severe Toxicity to Fluoropyrimidines: An Extreme Phenotype Approach. Journal of personalized medicine 11 (8) (2021)
MBelén Marzal-Alfaro, Carmen Guadalupe Rodriguez-Gonzalez, Vicente Escudero-Vilaplana, José Luis Revuelta-Herrero, Eva González-Haba, Sara Ibáñez-Garcia, Irene Iglesias-Peinado, Ana Herranz-Alonso, Maria Sanjurjo Saez
Risks and medication errors analysis to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients' safety. Health informatics journal 26 (3) (2020)
Alejandra Melgarejo-Ortuño, Vicente Escudero-Vilaplana, José Luis Revuelta-Herrero, Rebeca Bailen Almorox, Roberto Collado-Borrell, Ignacio Gomez-Centurión, Guillen Oarbeascoa, Mi Kwon, Ana Herranz-Alonso, Jose Luis Diez-Martin, Maria Sanjurjo-Saez
Tocilizumab as salvage treatment of refractory pulmonary acute graft-versus-host disease. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 27 (3) (2020)
José Luis Revuelta-Herrero, Raquel García-Sánchez, Javier Anguita-Velasco, Ana de Lorenzo-Pinto, Cristina Ortega-Navarro, María Sanjurjo-Sáez
Drug safety surveillance within a strategy for the management of non-chemotherapy drug-induced neutropenia. International journal of clinical pharmacy 41 (5) (2019)
Vicente Escudero-Vilaplana, José Luis Revuelta-Herrero, Roberto Collado-Borrell, Belen Marzal-Alfaro, Alvaro Gimenez-Manzorro, Ana Herranz-Alonso, María Sanjurjo-Saez
Oral antineoplastic agents: assessment of safety and dose adjustments in clinical practice. Expert opinion on drug safety 18 (9) (2019)
José Luis Revuelta-Herrero, A Giménez-Manzorro, A Matilla-Peña, A Herranz-Alonso, M Sanjurjo-Sáez
Concomitant use of sorafenib with ombitasvir/paritaprevir/ritonavir and dasabuvir: Effectiveness and safety in clinical practice. Journal of clinical pharmacy and therapeutics 43 (6) (2018)